Infusion Drug Delivery Resources
-
Contract Design And Development Vs. In-House: How To Find The Best Fit
3/21/2024
Explore the rationale behind opting for a contract development organization (CDO) to fulfill organizational requirements and underscore vital considerations for evaluating CDOs to ensure alignment with your project objectives.
-
Hospital To Home: What It Means For Patients, Providers And Medical Devices
4/16/2025
Healthcare is shifting homeward. With telehealth, connected devices, and user-friendly design, patients and caregivers now deliver hospital-level care safely and effectively outside clinical settings.
-
Is Your Combination Product Drug-Led Or Device-Led?
11/30/2022
The $118 billion combination-product market is projected to increase at a CAGR of 8.8%. This article answers the question: “Is this actually a combination product? What do we need to do if it is?”
-
Bag Flling Is Now Possible In The United States
2/10/2023
Explore the reasons why one CDMO is expanding its operations to offer flexible bag filling, after being equipped with filling lines for PFS and glass vials (glass or plastic).
-
Innovative Formulation Technologies By 505(b)(2) Regulatory Pathway
1/24/2022
Revitalization of older marketed drugs using innovative drug delivery technologies can provide new marketing exclusivity and patent protection, offering an effective tool for product life cycle management.
-
Formulation Research Strategy For Discovery- Stage New Drug Candidates
1/24/2022
Early stage formulation studies, which should support the emerging target product profile, will often yield important experimental results to aid subsequent development of clinically relevant dosage forms.
-
Rational Design And Development Of Long-Acting Injectable Dosage Forms
1/26/2022
The increasing prevalence of chronic disorders, growing demand for self-administration, and the increasing demand for minimally invasive surgeries have fueled the growth of the LAI drug delivery market.
-
Formulation Development From Preclinical To First-In-Human
1/24/2022
A compound with poor biopharmaceutical properties or improper formulation design could lead to a delay in the project or even program termination.
-
Accelerating Gene Therapy With HITSCAN Platform
4/16/2025
Battelle’s HIT SCAN™ platform accelerates gene therapy by rapidly designing, screening, and optimizing nanoparticle drug delivery systems using high-throughput robotics and machine learning.
-
10 Ways To Align Your Medical Device With Human Factors Industry Best Practices
3/1/2024
Discover how patient-centric design principles can improve the development of medical devices. By focusing on user needs and behaviors, manufacturers can ensure that products align with expectations.